Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints
High-performance metabolic analysis is emerging in the diagnosis and prognosis of breast
cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of …
cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of …
[HTML][HTML] Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints
Y Huang, S Du, J Liu, W Huang, W Liu… - Proceedings of the …, 2022 - ncbi.nlm.nih.gov
NPELDI-MS. To improve the analytical speed, sample consumption, and reproducibility of
LDI-MS, we conducted highperformance serum metabolic fingerprinting by NPELDI-MS (Fig …
LDI-MS, we conducted highperformance serum metabolic fingerprinting by NPELDI-MS (Fig …
Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints
Y Huang, S Du, J Liu, W Huang… - Proceedings of the …, 2022 - pubmed.ncbi.nlm.nih.gov
High-performance metabolic analysis is emerging in the diagnosis and prognosis of breast
cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of …
cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of …
Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints
Y Huang, S Du, J Liu, W Huang… - Proceedings of the …, 2022 - researchwithrutgers.com
High-performance metabolic analysis is emerging in the diagnosis and prognosis of breast
cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of …
cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of …
Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints
Y Huang, S Du, J Liu, W Huang, W Liu… - Proceedings of the …, 2022 - ui.adsabs.harvard.edu
Breast cancer (BrCa) is the most common cancer worldwide, and high-performance
metabolic analysis is emerging in diagnosis and prognosis of BrCa. Here, we used …
metabolic analysis is emerging in diagnosis and prognosis of BrCa. Here, we used …
Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints.
Y Huang, S Du, J Liu, W Huang, W Liu… - Proceedings of the …, 2022 - europepmc.org
NPELDI-MS. To improve the analytical speed, sample consumption, and reproducibility of
LDI-MS, we conducted highperformance serum metabolic fingerprinting by NPELDI-MS (Fig …
LDI-MS, we conducted highperformance serum metabolic fingerprinting by NPELDI-MS (Fig …